ATE557082T1 - Sequenz positionen zur anpassung bei prrsv - Google Patents
Sequenz positionen zur anpassung bei prrsvInfo
- Publication number
- ATE557082T1 ATE557082T1 AT02076334T AT02076334T ATE557082T1 AT E557082 T1 ATE557082 T1 AT E557082T1 AT 02076334 T AT02076334 T AT 02076334T AT 02076334 T AT02076334 T AT 02076334T AT E557082 T1 ATE557082 T1 AT E557082T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- positions
- arterivirus
- specifically
- amino acids
- Prior art date
Links
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 title abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 6
- 150000001413 amino acids Chemical group 0.000 abstract 6
- 238000000034 method Methods 0.000 abstract 4
- 241000700605 Viruses Species 0.000 abstract 3
- 241000867607 Chlorocebus sabaeus Species 0.000 abstract 2
- 101150034914 GP2a gene Proteins 0.000 abstract 2
- SPEFJYZGXZENAF-UHFFFAOYSA-N N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide Chemical compound C=1C(C)=CC=C(C2=3)C=1CC=3C(C(=O)NC1CCCCC1)=NN2C1=CC=C(Cl)C=C1Cl SPEFJYZGXZENAF-UHFFFAOYSA-N 0.000 abstract 2
- 230000001018 virulence Effects 0.000 abstract 2
- 230000006978 adaptation Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
- C12N2770/10064—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076334A EP1350840B1 (en) | 2002-04-05 | 2002-04-05 | Adaptation sites of PRRSV |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE557082T1 true ATE557082T1 (de) | 2012-05-15 |
Family
ID=27838115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02076334T ATE557082T1 (de) | 2002-04-05 | 2002-04-05 | Sequenz positionen zur anpassung bei prrsv |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7312030B2 (enExample) |
| EP (1) | EP1350840B1 (enExample) |
| JP (1) | JP4477307B2 (enExample) |
| AT (1) | ATE557082T1 (enExample) |
| CA (1) | CA2424400C (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| PL204373B1 (pl) * | 1999-03-08 | 2010-01-29 | Boehringer Ingelheim Vetemendi | Replikony zespołu reprodukcyjnego i oddechowego świń (PRRSV), zastosowanie replikonów PRRSV, szczepionki zawierające replikony PRRSV i zastosowanie tych szczepionek |
| AU4482200A (en) * | 1999-04-22 | 2000-11-10 | United States Department Of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| SG153829A1 (en) * | 2004-06-18 | 2009-07-29 | Univ Minnesota | Identifying virally infected and vaccinated organisms |
| US7632636B2 (en) * | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
| WO2006055331A2 (en) * | 2004-11-19 | 2006-05-26 | Intervet International B.V. | Porcine reproductive and respiratory syndrome virus strains and compositions |
| PL2369001T3 (pl) | 2005-06-24 | 2017-06-30 | Regents Of The University Of Minnesota | Wirusy PRRS, ich klony zakaźne, mutanty i sposoby stosowania |
| EP1929047B1 (en) * | 2005-08-30 | 2010-03-17 | Board of Regents of the University of Nebraska | Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity |
| WO2009014919A2 (en) * | 2007-07-13 | 2009-01-29 | Iowa State University Research Foundation, Inc. | H2n3 influenza a viruses and methods of use |
| US20110117129A1 (en) * | 2008-08-25 | 2011-05-19 | Boehringer Ingelheim Vetmedica, Inc. | Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS) |
| AR078253A1 (es) * | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| PL2675475T3 (pl) | 2011-02-17 | 2015-12-31 | Boehringer Ingelheim Vetmedica Gmbh | Nowy europejski szczep prrs |
| EP2675476B1 (en) | 2011-02-17 | 2015-09-16 | Boehringer Ingelheim Vetmedica GmbH | Commercial scale process for production of prrsv |
| WO2013017568A1 (en) | 2011-07-29 | 2013-02-07 | Boehringer Ingelheim Vetmedica Gmbh | INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF |
| US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
| US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
| JP6886291B2 (ja) | 2013-12-20 | 2021-06-16 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ | ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用 |
-
2002
- 2002-04-05 AT AT02076334T patent/ATE557082T1/de active
- 2002-04-05 EP EP02076334A patent/EP1350840B1/en not_active Expired - Lifetime
-
2003
- 2003-04-03 CA CA2424400A patent/CA2424400C/en not_active Expired - Fee Related
- 2003-04-04 US US10/407,822 patent/US7312030B2/en not_active Expired - Lifetime
- 2003-04-04 JP JP2003102066A patent/JP4477307B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004121220A (ja) | 2004-04-22 |
| US20030219732A1 (en) | 2003-11-27 |
| US7312030B2 (en) | 2007-12-25 |
| EP1350840B1 (en) | 2012-05-09 |
| CA2424400A1 (en) | 2003-10-05 |
| JP4477307B2 (ja) | 2010-06-09 |
| EP1350840A1 (en) | 2003-10-08 |
| CA2424400C (en) | 2012-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE557082T1 (de) | Sequenz positionen zur anpassung bei prrsv | |
| DK1476541T3 (da) | Cytokin (zcytor17-ligand) | |
| SG171577A1 (en) | Methods for producing yeast-based vaccines | |
| DK1680509T3 (da) | Fremgangsmåde til fremstilling af carbonhydrider og oxygenholdige forbindelser fra biomasse der inkluderer fermentation med tilsætning af aminosyre (leu, ile, val) | |
| DE50214630D1 (de) | Verfahren zur grosstechnischen herstellung von impfstoffen | |
| DK1082293T3 (da) | Formoterol-polymorfer | |
| NO20014364D0 (no) | Ny cytokin-zalphall-ligand | |
| ATE501264T1 (de) | Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate | |
| NO20074895L (no) | Isoksazolin derivat og ny fremgangsmate for fremstilling derav | |
| DE60042035D1 (de) | Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen | |
| EA200400195A1 (ru) | Способ репродукции вируса | |
| BRPI0410861A (pt) | métodos e composições para a produção de aminoácidos | |
| ITMI20022076A1 (it) | Sali di intermedi del cefdinir. | |
| BR0303570A (pt) | Gene de fator de crescimento de hepatócito hìbrido tendo eficiência de expressão elevada de dois heterotipos de fator de crescimento de hepatócito | |
| ATE354648T1 (de) | Verfahren zur herstellung eines virus inaktivierten thrombin präparates | |
| EA200801109A1 (ru) | Состав для литья и способ его получения | |
| DK1200561T3 (da) | Rekombinant stabil celleklon, dens fremstilling og anvendelse | |
| WO2006021559A3 (de) | Verfahren zur herstellung von tiotropiumsalzen und silicium-derivate als zwischenprodukte | |
| DK1127886T3 (da) | Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on | |
| ATE542810T1 (de) | Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton | |
| ATE391115T1 (de) | Verfahren zur herstellung von diketenacetalen | |
| DK1156058T3 (da) | Fremgangsmåde til fremstilling af (E,Z) 3-(2-aminoethoxyimino)-androstan-6,17-dion og analoger deraf | |
| UA100849C2 (ru) | Способ репликации вируса гриппа в культуре | |
| ITMI20032172A1 (it) | Procedimento atto alla correzione dell'arricchimento di | |
| DK1501838T3 (da) | Fremgangsmåde til fremstilling af clopidogrel |